Skip to main content
SpringerLink
Log in

Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of the present investigation was to increase the solubility and dissolution rate of rofecoxib by the preparation of its solid dispersion with polyvinyl pyrrolidone K30 (PVP K30) using solvent evaporation method. Drug-polymer interactions were investigated using differential scanning calorimetry (DSC), x-ray diffraction (XRD), and Fourier transform infrared spectroscopy (FTIR). For the preparation of rofecoxib mouth dissolve tablets, its 1∶9 solid dispersion with PVP K30 was used with various disintegrants and sublimable materials. In an attempt to construct a statistical model for the prediction of disintegration time and percentage friability, a 32 randomized full and reduced factorial design was used to optimize the influence of the amounts of superdisintegrant and subliming agent. The obtained results showed that dispersion of the drug in the polymer considerably enhanced the dissolution rate. The drug-to-carrier ratio was the controlling factor for dissolution improvement. FTIR spectra revealed no chemical incompatibility between the drug and PVP K30. As indicated from XRD and DSC data, rofecoxib was in the amorphous form, which explains the better dissolution rate of the drug from its solid dispersions. Concerning the optimization study, the multiple regression analysis revealed that an optimum concentration of camphor and a higher percentage of crospovidone are required for obtaining rapidly disintegrating tablets. In conclusion, this investigation demonstrated the potential of experimental design in understanding the effect of the formulation variables on the quality of mouth dissolve tablets containing solid dispersion of a hydrophobic drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Van den Mooter G, Wuyts M, Blaton N, et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci. 2001; 12: 261–269.

    Article  Google Scholar 

  2. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersions. J Pharm Sci. 1971; 60: 1281–1302.

    Article  CAS  Google Scholar 

  3. Esnaashari S, Javadzadeh Y, Batchelor HK, Conway BR. The use of microviscometry to study polymer dissolution from solid dispersion drug delivery systems. Int J Pharm. 2005; 292: 227–230.

    Article  CAS  Google Scholar 

  4. Van den Mooter G, Augustijns P, Blaton N, Kinget R. Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm. 1998; 164: 67–80.

    Article  Google Scholar 

  5. Liu C, Desai KG. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions. Pharm dev Technol. 2005; 10: 467–477.

    Article  CAS  Google Scholar 

  6. Rawat S, Jain SK. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement. Pharmazie. 2003; 58: 639–641.

    CAS  Google Scholar 

  7. Masaki K. Orally disintegrating famotidine tablets. 22nd Conference on Pharmaceutical Technology; July 15–17, 1997; Kisarazu, Japan Tokyo, Japan: Academy of Pharmaceutical Science and Technology; 1997: 79–84.

    Google Scholar 

  8. Corveleyn S, Remon JP. Formulation and production of rapidly disintegrating tablets by lyophilization using hydrochlorothiazide as a model drug. Int J Pharm. 1997; 152: 215–225.

    Article  CAS  Google Scholar 

  9. Roser BJ, Blair J, inventors. Rapidly soluble oral dosage forms, method of making some, and composition thereof. US patent 5 762 961. June 9, 1998.

  10. Franco M, Trapani G, Latrofa A, et al. Dissolution properties and anticonvulsant activity of phenytoin-polyethylene glycol 6000 and-polyvinylpyrrolidone K-30 solid dispersions. Int J Pharm. 2001; 225: 63–73.

    Article  CAS  Google Scholar 

  11. Arias MJ, Gins JM, Moyano JR, Rabasco AM. Influence of the preparation method of solid dispersions on their dissolution rate: study of triamterene-D-mannitol system. Int J Pharm. 1995; 123: 25–31.

    Article  CAS  Google Scholar 

  12. Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instrum. 1965; 4: 117–210.

    CAS  Google Scholar 

  13. Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2004; 272: 1–10.

    Article  Google Scholar 

  14. Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS PharmSciTech. 2004; 5:E36.

    Google Scholar 

  15. Seedher N, Bhatia S. Solubility enhancement of Cox-2 inhibitors using various solvent systems. AAPS PharmSciTech. 2003; 4: E33.

    Article  CAS  Google Scholar 

  16. Abdul-Fattah AM, Bhargava HN. Preparation and in vitro evaluation of solid dispersions of halofantrine. Int J Pharm. 2002; 235: 17–33.

    Article  CAS  Google Scholar 

  17. Torrado S, Torrado J, Cadorniga R. Preparation, dissolution and characterization of albendazole solid dispersions. Int J Pharm. 1996; 140: 247–250.

    Article  CAS  Google Scholar 

  18. Torre P, Torrado S, Santiago T. Preparation, dissolution and characterization of praziquantel solid dispersions. Chem Pharm Bull (Tokyo). 1999; 47: 1629–1633.

    Google Scholar 

  19. Edward MR, ed. Oral solid dosage forms. In: Remington’s pharmaceutical Science. Easton, PA: Mack Publishing; 2000:858–893.

    Google Scholar 

  20. Koizumi K, Watanabe Y, Morita K, Utoguchi N, Matsumoto M. New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int J Pharm. 1997; 152: 127–131.

    Article  CAS  Google Scholar 

  21. Mendenhall W, Sincich T, eds. Multiple regression. In: A Second Course in Business Statistics: Regression Analysis. 3rd ed. San Francisco, CA: Dellen Publishing Co; 1989: 141–226.

    Google Scholar 

Download references

Author information

Author notes

  1. Ahmed S. Zidan

    Present address: FDA/CDER, White Oaks Life Science, Building 64, Room 1083, 10903 New Hampshire Ave, Silver Spring, MD

Authors and Affiliations

  1. School of Pharmacy, Zagazig University, Zagazig, Egypt

    Omaima A. Sammour, Mohammed A. Hammad, Nagia A. Megrab & Ahmed S. Zidan

  2. School of Pharmacy, Howard University, Washington, DC

    Ahmed S. Zidan

Authors
  1. Omaima A. Sammour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammed A. Hammad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nagia A. Megrab
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmed S. Zidan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed S. Zidan.

Additional information

Published: June 16, 2006

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sammour, O.A., Hammad, M.A., Megrab, N.A. et al. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech 7, 55 (2006). https://doi.org/10.1208/pt070255

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt070255

Keywords

Search

Navigation